Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 05 04:00PM ET
6.88
Dollar change
-0.08
Percentage change
-1.15
%
Index- P/E- EPS (ttm)-0.50 Insider Own29.92% Shs Outstand17.33M Perf Week8.35%
Market Cap119.23M Forward P/E125.09 EPS next Y0.06 Insider Trans0.00% Shs Float12.14M Perf Month4.98%
Income-8.67M PEG- EPS next Q-0.11 Inst Own0.74% Short Float0.03% Perf Quarter32.49%
Sales27.70M P/S4.30 EPS this Y55.94% Inst Trans50.16% Short Ratio0.14 Perf Half Y13.06%
Book/sh-0.05 P/B- EPS next Y115.60% ROA-43.89% Short Interest0.00M Perf Year11.82%
Cash/sh0.20 P/C35.07 EPS next 5Y- ROE-5955.96% 52W Range4.66 - 7.38 Perf YTD11.33%
Dividend Est.- P/FCF- EPS past 5Y45.00% ROI-113.21% 52W High-6.78% Beta1.29
Dividend TTM- Quick Ratio0.30 Sales past 5Y158.55% Gross Margin56.07% 52W Low47.64% ATR (14)0.29
Dividend Ex-Date- Current Ratio0.51 EPS Y/Y TTM62.74% Oper. Margin-26.29% RSI (14)61.60 Volatility4.55% 2.63%
Employees87 Debt/Eq- Sales Y/Y TTM74.76% Profit Margin-31.30% Recom1.00 Target Price13.67
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q71.83% Payout- Rel Volume0.13 Prev Close6.96
Sales Surprise0.65% EPS Surprise-8.33% Sales Q/Q47.08% EarningsMay 15 AMC Avg Volume23.50K Price6.88
SMA206.42% SMA5010.21% SMA20018.31% Trades Volume3,098 Change-1.15%
Date Action Analyst Rating Change Price Target Change
May-05-25Initiated Craig Hallum Buy $15
Dec-18-24Initiated Maxim Group Buy $12
Jun-04-25 07:00AM
Jun-03-25 08:50AM
May-21-25 08:30AM
08:00AM
May-15-25 05:45PM
04:05PM Loading…
04:05PM
May-13-25 07:15AM
May-12-25 08:30AM
May-08-25 10:00AM
08:15AM
May-07-25 05:25PM
May-06-25 06:30PM
May-01-25 08:30AM
Apr-15-25 07:20AM
Apr-10-25 10:10AM
08:54PM Loading…
Mar-31-25 08:54PM
05:45PM
04:05PM
Mar-26-25 08:10AM
Mar-17-25 08:30AM
Mar-06-25 08:30AM
Mar-04-25 08:30AM
Feb-18-25 08:30AM
Feb-12-25 08:30AM
Jan-22-25 07:00AM
03:30AM
Jan-08-25 08:40AM
Dec-11-24 01:00AM
Dec-02-24 08:00AM
Nov-25-24 04:05PM
03:30AM Loading…
03:30AM
Nov-21-24 08:30AM
Nov-18-24 08:30AM
Nov-12-24 08:30AM
BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm engages in botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions. It offers nutraceutical health and wellness products, which includes dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.